Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures
An Observational Study to Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures
1 other identifier
observational
15
1 country
1
Brief Summary
Massive number of clinicians were infected during the outbreak of COVID-19, which raised the concerns of utilizing "aerosol generating procedures", particularly the use of high-flow nasal cannula, noninvasive ventilation, intubation, bronchoscopy examination and pulmonary function test. There appears to be a trend to avoid those treatments. Instead, aggressive intubation might cause shortage of medical devices and add extra workload. Therefore, we aimed to do a clinical observational study to evaluate the aerosol generation in these procedures and explore the potential measures to reduce the aerosol generation or dispersion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2020
CompletedFirst Posted
Study publicly available on registry
April 20, 2020
CompletedStudy Start
First participant enrolled
May 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2020
CompletedApril 23, 2021
April 1, 2021
3 months
March 23, 2020
April 21, 2021
Conditions
Outcome Measures
Primary Outcomes (8)
The aerosol mass/count concentration pre procedure/treatment at 1 foot away from patient
The aerosol mass/count concentration pre procedure/treatment at 1 foot away from patient's airway in the patient's room
5 minutes before procedure/treatment
The virus load in the air sample pre procedure/treatment at 1 foot away from patient
The virus load in the air sample pre procedure/treatment at 1 foot away from patient's airway in the patient's room
1 hour before procedure/treatment
The virus load in the air sample during/after procedure/treatment at 1 foot away from patient
The virus load in the air sample during/after procedure/treatment at 1 foot away from patient's airway in the patient's room
1 hour during/after procedure/treatment
The aerosol mass/count concentration pre procedure/treatment at 3 feet away from patient
The aerosol mass/count concentration pre procedure/treatment at 3 feet away from patient's airway in the patient's room
5 minutes before procedure/treatment
The aerosol mass/count concentration and virus load in the air sample during procedure/treatment at 1 foot away from patient
The aerosol mass/count concentration and virus load in the air sample during procedure/treatment at 1 foot away from patient's airway in the patient's room
during procedure/treatment
The aerosol mass/count concentration during procedure/ treatment at 3 feet away from patient
The aerosol mass/count concentration during procedure/ treatment at 3 feet away from HFNC in the patient's room
during procedure/treatment
The aerosol mass/count concentration post procedure/ treatment at 1 foot away from patient
The aerosol mass/count concentration post procedure/ treatment at 1 foot away from HFNC in the patient's room
5 minutes post procedure/treatment
The aerosol mass/count concentration 5 mins post procedure/ treatment at 3 feet away from patient
The aerosol mass/count concentration 5 mins procedure/ treatment at 3 feet away from HFNC in the patient's room
5 minutes post procedure/treatment
Interventions
High-flow nasal cannula is a modality of oxygen device that can provide gas flow meets or exceeds patient inspiratory flow demand (flow can be set at 10-60 L/min), it has been proven to improve oxygenation and reduce intubation rate in hypoxemic patients.
A procedure mask will be used to cover patient's face after HFNC is initiated.
is a procedure that allows a doctor to examine the inside of the lungs, including the bronchi, which are the main pathways into the lungs. During a bronchoscopy, a doctor inserts a thin tube containing a light and camera into the lungs through the nose or mouth or via artificial airway such as intubation or tracheotomy tube
Intubation is the process of inserting a tube, called an endotracheal tube (ET), through the mouth and then into the airway. This is done so that a patient can be placed on a ventilator to assist with breathing during anesthesia, sedation, or severe illness.
A tracheostomy is a medical procedure - either temporary or permanent - that involves creating an opening in the neck in order to place a tube into a person's windpipe. The tube is inserted through a cut in the neck below the vocal cords. This allows air to enter the lungs.
A nebulizer is a piece of medical equipment that a person with asthma or another respiratory condition can use to administer medication directly and quickly to the lungs
Pulmonary function tests (PFTs) are noninvasive tests that show how well the lungs are working. The tests measure lung volume, capacity, rates of flow, and gas exchange.
Eligibility Criteria
Adult patients who are diagnosed as COVID-19 infection and admitted to adult ICU will be enrolled in Rush University Medical Center, Chicago, IL, USA. Patients will be excluded if patients do not require any respiratory treatments.
You may qualify if:
- Adult patients who are diagnosed as COVID-19 infection in ICU or Adult patients are indicated for pulmonary function tests
You may not qualify if:
- No need for any respiratory therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rush university medical center
Chicago, Illinois, 60612, United States
Related Publications (6)
Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. 2020 Apr 28;323(16):1610-1612. doi: 10.1001/jama.2020.3227.
PMID: 32129805BACKGROUNDHui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS, Gin T, Chan MTV. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J. 2019 Apr 11;53(4):1802339. doi: 10.1183/13993003.02339-2018. Print 2019 Apr.
PMID: 30705129BACKGROUNDLeung CCH, Joynt GM, Gomersall CD, Wong WT, Lee A, Ling L, Chan PKS, Lui PCW, Tsoi PCY, Ling CM, Hui M. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. J Hosp Infect. 2019 Jan;101(1):84-87. doi: 10.1016/j.jhin.2018.10.007. Epub 2018 Oct 15.
PMID: 30336170BACKGROUNDHui DS, Chow BK, Chu L, Ng SS, Lee N, Gin T, Chan MT. Exhaled air dispersion during coughing with and without wearing a surgical or N95 mask. PLoS One. 2012;7(12):e50845. doi: 10.1371/journal.pone.0050845. Epub 2012 Dec 5.
PMID: 23239991BACKGROUNDJohnson DF, Druce JD, Birch C, Grayson ML. A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis. 2009 Jul 15;49(2):275-7. doi: 10.1086/600041.
PMID: 19522650BACKGROUNDLi J, Jing G, Fink JB, Porszasz J, Moran EM, Kiourkas RD, McLaughlin R, Vines DL, Dhand R. Airborne Particulate Concentrations During and After Pulmonary Function Testing. Chest. 2021 Apr;159(4):1570-1574. doi: 10.1016/j.chest.2020.10.064. Epub 2020 Nov 1. No abstract available.
PMID: 33144080DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jie Li, PhD
Rush University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2020
First Posted
April 20, 2020
Study Start
May 20, 2020
Primary Completion
August 30, 2020
Study Completion
August 30, 2020
Last Updated
April 23, 2021
Record last verified: 2021-04